ABVC BioPharma, Inc. (ABVC) stock
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
$0.94+0.03 (+3.30%)
Close on Nov 16, 2026Market cap $25.06MP/E –Yield –
ABVC BioPharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
ABVC BioPharma's price to sales ratio was 49.7× on Apr 30, 2025, against 65.1× a year earlier. Over the last 4 years it ranged from 4.5× to 334.9×, with a median of 80.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Apr 30, 2025 | 49.7× | +35.0 |
| 2024 | Dec 31, 2024 | 14.7× | +7.1 |
| 2023 | Dec 29, 2023 | 7.6× | −145.7 |
| 2022 | Jan 31, 2022 | 153.2× | −54.6 |
| 2021 | Dec 31, 2021 | 207.8× | +8.1 |
| 2020 | Dec 31, 2020 | 199.7× | – |
See a number that looks wrong?